Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal ...
Mena FN5d
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. To Its Board Of Directors
and the early launch of Rezdiffra has demonstrated the compelling benefit that this innovative medicine represents for patients. I look forward to working with this team that has successfully ...
Nasdaq4d
Madrigal Pharmaceuticals Announces Dr. Fred Craves' Retirement and Appointment of Dr. Jacqualyn Fouse to Board of Directors
and the early launch of Rezdiffra has demonstrated the compelling benefit that this innovative medicine represents for patients. I look forward to working with this team that has successfully ...
Everyday Health3d
Consumer's Guide to THR-Beta Agonists for MASH
THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe ...
Yahoo Finance5d
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
I look forward to working with her to drive the launch of Rezdiffra, expand geographically, advance our clinical program in compensated MASH cirrhosis, and build our pipeline. I’d also like to ...